SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
A. E. Chaouat, H. Achdout, I. Kol, O. Berhani, G. Roi, E. B. Vitner, S. Melamed, B. Politi, E. Zahavi, I. Brizic, T. Lenac Rovis, O. B. Alfi, D. Wolf, S. Jonjic, T. Israely, O. Mandelboim
This paper develops RBD-Ig fusion proteins that efficiently neutralize SARS-CoV-2 infection in vitro and in vivo, outperforming ACE2-Ig.
bioRxiv · Apr 18, 2021Immunology